Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the difference between vitamin C in the form of oral liposomes and general vitamin C in a fixed period of time in plasma and urine.
we recruited 11 healthy subjects and adopted a cross-over test. the subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start. The subjects were informed to consume one sachet vitamin C without liposome, liposomal process A vitamin C, or liposomal process B vitamin C (Double Nutri™) every test, and vitamin C concentration was measured at baseline (0 hours), 0.5, 1, 2, 3, 4, and 8 hours after taking test sample.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| vitamin C without liposome | Sham Comparator | vitamin C without liposome |
|
| liposomal process A vitamin C | Placebo Comparator | liposomal process A vitamin C |
|
| liposomal process B vitamin C (Double Nutri™) | Experimental | liposomal process B vitamin C (Double Nutri™) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| vitamin C without liposome | Dietary Supplement | subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start |
| Measure | Description | Time Frame |
|---|---|---|
| vitamin c detection | vitamin c was assessed by Ascorbic Acid Colorimetric Assay Kit II | at 8 hours after taking test sample |
| The change of Triglyceride | Venous blood was sampled to measure concentrations of Triglyceride | at 8 hours after taking test sample |
| The change of body mass index (BMI) | BMI is a measurement of a person's leanness or corpulence based on their height and weight, and is intended to quantify tissue mass.The body mass index (BMI, kg/m^2) and body mass (kg) were assessed by InBody770. | Time 0, 0.5, 1, 2, 3, 4, and 8 hours after taking test sample |
| The change of aspartate aminotransferase | Venous blood was sampled to measure concentrations of aspartate aminotransferase | at 8 hours after taking test sample |
| The change of alanine aminotransferase | Venous blood was sampled to measure concentrations of alanine aminotransferase | at 8 hours after taking test sample |
| The change of creatine | Venous blood was sampled to measure concentrations of creatine | at 8 hours after taking test sample |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jaw-Shiun Tsai, Doctor | National Taiwan University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research & Design Center, TCI CO., Ltd | Taipei | 114 | Taiwan |
Not provided
| ID | Term |
|---|---|
| D001206 | Ascorbic Acid Deficiency |
| ID | Term |
|---|---|
| D001361 | Avitaminosis |
| D003677 | Deficiency Diseases |
| D044342 | Malnutrition |
| D009748 | Nutrition Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D001205 | Ascorbic Acid |
| D008081 | Liposomes |
| ID | Term |
|---|---|
| D013400 | Sugar Acids |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| liposomal process A vitamin C | Dietary Supplement | subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start |
|
| liposomal process B vitamin C (Double Nutri™) | Dietary Supplement | subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start |
|
| D009750 |
| Nutritional and Metabolic Diseases |
| D006880 |
| Hydroxy Acids |
| D002241 | Carbohydrates |
| D008567 | Membranes, Artificial |
| D001697 | Biomedical and Dental Materials |
| D004337 | Drug Carriers |
| D004304 | Dosage Forms |
| D004364 | Pharmaceutical Preparations |
| D008420 | Manufactured Materials |
| D013676 | Technology, Industry, and Agriculture |
| D040761 | Biomimetic Materials |